Semaglutide is a glucagon-like peptide- receptor agonist GLP- RA that mimics the GLP- hormone helping reduce blood sugar and suppress appetite It is FDA-approved for chronic weight management in non-diabetics under the brand name Wegovy with the typical dose for weight loss being mg administered weekly as a subcutaneous injection Randomized control trials have shown semaglutide to be highly effective for weight loss in non-diabetic adults with obesity with half the participants losing of their body weight and nearly a third losing This comprehensive guide will explore semaglutide's mechanism of action dosage and administration effectiveness for weight loss factors influencing weight loss outcomes dietary considerations and how to obtain this medication It will also address common side effects like nausea diarrhea constipation headaches fatigue dizziness and vomiting associated with semaglutide Mechanism of Action Semaglutide is a glucagon-like peptide- receptor agonist GLP- RA that mimics the naturally occurring hormone GLP- which controls appetite and induces feelings of fullness leading to weight loss It was initially approved for treating type diabetes but has since been approved by the FDA for chronic weight management in obese or overweight individuals The mechanism of action of semaglutide involves Suppressing Appetite Semaglutide interacts with the parts of the brain that suppress appetite and signal feelings of fullness It targets the brain centers that regulate appetite especially after eating which may help you eat less Slowing Digestion Semaglutide slows down how quickly the stomach empties which makes you feel fuller for longer This delayed gastric emptying contributes... Login to read full